MGMT and glioblastoma: Methylation of CpG island in MGMT promoter area has been found to cause epigenetic silence of MGMT, which was observed in 45% of GBM patients.[174] Thus, silencing MGMT and its subsequent loss of protein expression could serve as a promising therapeutic target.